Skip to main content
Top
Published in: BMC Public Health 1/2021

Open Access 01-12-2021 | Lymphadenectomy | Research article

Colon cancer survival differs from right side to left side and lymph node harvest number matter

Authors: Lucia Mangone, Carmine Pinto, Pamela Mancuso, Marta Ottone, Isabella Bisceglia, Giorgio Chiaranda, Maria Michiara, Massimo Vicentini, Giuliano Carrozzi, Stefano Ferretti, Fabio Falcini, Cesare Hassan, Paolo Giorgi Rossi

Published in: BMC Public Health | Issue 1/2021

Login to get access

Abstract

Background

Right-sided colorectal cancer (CRC) has worse survival than does left-sided CRC. The objective of this study was to further assess the impact of right-side location on survival and the role of the extent of lymphadenectomy.

Methods

All CRCs diagnosed between 2000 and 2012 in Emilia-Romagna Region, Italy, were included. Data for stage, grade, histology, screening history, and number of removed lymph nodes (LN) were collected. Multivariable Cox regression models were used to estimate hazard ratios (HR), with relative 95% confidence intervals (95%CI), of right vs. left colon and of removing < 12, 12–21 or > 21 lymph nodes by cancer site.

Results

During the study period, 29,358 patients were registered (8828 right colon, 18,852 left colon, 1678 transverse). Patients with right cancer were more often older, females, with advanced stage and high grade, and higher number of removed LNs. Five-year survival was lower in the right than in the left colon (55.2% vs 59.7%). In multivariable analysis, right colon showed a lower survival when adjusting for age, sex, and screening status (HR 1.12, 95%CI 1.04–1.21). Stratification by number of lymph nodes removed (12–21 or > 21) was associated with better survival in right colon (HR 0.54, 95%CI 0.40–0.72 and HR 0.40, 95%CI 0.30–0.55, respectively) compared to left colon (HR 0.89, 95%CI 0.76–1.06 and HR 0.83, 95%CI 0.69–1.01, respectively).

Conclusions

This study confirms that right CRC has worse survival; the association is not due to screening status. An adequate removal of lymph nodes is associated with better survival, although the direction of the association in terms of causal links is not clear.
Appendix
Available only for authorised users
Literature
1.
go back to reference IAIOM-AIRTUM-PASSI-PASSI D'ARGENTO- SIAPEC-IAP. I numeri del cancro in Italia 2019. Intermedia editore, September 2019. IAIOM-AIRTUM-PASSI-PASSI D'ARGENTO- SIAPEC-IAP. I numeri del cancro in Italia 2019. Intermedia editore, September 2019.
8.
go back to reference Lykke J, Rosenberg J, Jess P, Roikjaer O, Danish Colorectal Cancer Group. Lymph node yield and tumour subsite are associated with survival in stage I-III colon cancer: results from a national cohort study. World J Surg Oncol. 2019;17(1):62.CrossRef Lykke J, Rosenberg J, Jess P, Roikjaer O, Danish Colorectal Cancer Group. Lymph node yield and tumour subsite are associated with survival in stage I-III colon cancer: results from a national cohort study. World J Surg Oncol. 2019;17(1):62.CrossRef
10.
go back to reference Vergara-Fernandez O, Swallow CJ, Victor JC, O'Connor BI, Gryphe R, MacRae HM, et al. Assessing outcomes following surgery for colorectal cancer using quality of care indicators. Can J Surg. 2010;53(4):232–40.PubMedPubMedCentral Vergara-Fernandez O, Swallow CJ, Victor JC, O'Connor BI, Gryphe R, MacRae HM, et al. Assessing outcomes following surgery for colorectal cancer using quality of care indicators. Can J Surg. 2010;53(4):232–40.PubMedPubMedCentral
13.
go back to reference Fritz A, Percy C, Jack A, Shanmurgaratnam K, Sobin L, Parkin DM, Whelan S. International Classification of Disease for Oncology, 3rd ed (ICD-O-3). WHO; 2000. Fritz A, Percy C, Jack A, Shanmurgaratnam K, Sobin L, Parkin DM, Whelan S. International Classification of Disease for Oncology, 3rd ed (ICD-O-3). WHO; 2000.
14.
go back to reference Brierley JD, Gospodarowicz MK, Wittekind C.TNM Classification of Malignant Tumours, 8th ed. Wiley Blackwell; 2016. Brierley JD, Gospodarowicz MK, Wittekind C.TNM Classification of Malignant Tumours, 8th ed. Wiley Blackwell; 2016.
16.
go back to reference Loupakis F, Yang D, Yau L, Feng S, Cremolini C, Zhang W, et al. Primary tumor location as a prognostic factor in metastatic colorectal cancer. J Natl Cancer Inst. 2015;107(3):dju427.CrossRef Loupakis F, Yang D, Yau L, Feng S, Cremolini C, Zhang W, et al. Primary tumor location as a prognostic factor in metastatic colorectal cancer. J Natl Cancer Inst. 2015;107(3):dju427.CrossRef
27.
go back to reference Ow ZGW, Sim W, Nistala KRY, Ng CH, Koh FH, Wong NW, et al. Comparing complete mesocolic excision versus conventional colectomy for colon cancer: A systematic review and meta-analysis. Eur J Surg Oncol. 2020;S0748–7983(20):30778–2. Ow ZGW, Sim W, Nistala KRY, Ng CH, Koh FH, Wong NW, et al. Comparing complete mesocolic excision versus conventional colectomy for colon cancer: A systematic review and meta-analysis. Eur J Surg Oncol. 2020;S0748–7983(20):30778–2.
31.
go back to reference Baldacchini F, Bucchi L, Giuliani O, Mancini S, Ravaioli A, Vattiato R, et al. Results of Compliant Participation in Five Rounds of Fecal Immunochemical Test Screening for Colorectal Cancer. Clin Gastroenterol Hepatol. 2020;S1542–3565(20):31147–2. Baldacchini F, Bucchi L, Giuliani O, Mancini S, Ravaioli A, Vattiato R, et al. Results of Compliant Participation in Five Rounds of Fecal Immunochemical Test Screening for Colorectal Cancer. Clin Gastroenterol Hepatol. 2020;S1542–3565(20):31147–2.
Metadata
Title
Colon cancer survival differs from right side to left side and lymph node harvest number matter
Authors
Lucia Mangone
Carmine Pinto
Pamela Mancuso
Marta Ottone
Isabella Bisceglia
Giorgio Chiaranda
Maria Michiara
Massimo Vicentini
Giuliano Carrozzi
Stefano Ferretti
Fabio Falcini
Cesare Hassan
Paolo Giorgi Rossi
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2021
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-021-10746-4

Other articles of this Issue 1/2021

BMC Public Health 1/2021 Go to the issue